Mark A. Glickman is EVP - Sales and Marketing at AUXILIUM PHARMACEUTICALS INC (AUXL). They have made 3 open-market trades across 3 companies since 2014, most recently 2026-08-27.
CIK 0001441461
1 open-market purchase totalling $92K since 2016, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.